• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Drug Watch: Agents in late-stage development for the treatment of dermatologic disorders (January 2008) (PDF)

News
Article

Drugs in development as of January 2008 for the treatment of actinic keratosis, melanoma, andpsoriasis

Key Points













Selected websites

http://www.aad.org/
American Academy of Dermatology

http://www.nlm.nih.gov/medlineplus/psoriasis.html
MedlinePlus health information on psoriasis

http://www.niams.nih.gov/
National Institute of Arthritis and Musculoskeletal and Skin Diseases

http://www.psoriasis.org/
National Psoriasis Foundation

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.